Ribarin Tablet

About Ribarin 200 mg Tablet

Ribarin 200 mg Tablet is an antiviral medicine made by Renata PLC. It contains ribavirin and is used as part of combination treatment for chronic hepatitis C, and it is not taken on its own.

There are 5 brands of Ribavirin listed in Bangladesh. The lowest listed price is Celbarin 200 mg Capsule at ৳ 35.00 per unit.

What is Ribarin 200 mg Tablet?

Ribarin 200 mg Tablet is an antiviral medicine. It belongs to the group of medicines used for hepatic viral infections, specifically hepatitis C. It is prescribed together with other antiviral drugs for chronic hepatitis C infection in adults with compensated liver disease, including some patients who also have HIV. It is not used alone. Ribavirin works against several viruses, although the exact way it acts is not fully understood. Because it can harm an unborn baby, pregnancy testing and contraception are required around treatment. Only a qualified doctor should decide whether it is suitable for a particular patient.

Uses of Ribarin

Ribarin 200 mg Tablet is used to treat chronic hepatitis C virus infection in adults, always in combination with other antiviral medicines. It is prescribed for patients with compensated liver disease who have not been treated with interferon alpha before, and for some adult patients who also have HIV. It should not be used as a single medicine for hepatitis C. Your doctor will decide whether it fits your condition and treatment plan.

How to use Ribarin

Ribarin 200 mg Tablet is swallowed as your doctor directs. The dose, the number of times a day it is taken and the length of the course are decided by your doctor, based on your condition and the other medicines in your treatment. Do not change the schedule yourself. If you miss a dose or have side effects, contact your doctor or pharmacist rather than adjusting it on your own. Keep the tablet in a cool, dry place, away from light and out of children's reach.

Side effects of Ribarin

Combination treatment with ribavirin can cause psychiatric and central nervous system effects, severe eye problems, and dental and periodontal problems. In children and adolescents, growth may be inhibited, and in some patients this may be irreversible. Other side effects can occur, and some are serious. Tell your doctor promptly about any unusual symptoms, mood changes, vision problems or other concerns while taking this medicine. Your doctor will monitor you during treatment and decide what action is needed.

Safety and precautions

Ribarin 200 mg Tablet must not be used in pregnancy, and women who are or may become pregnant should not take it. Before treatment, patients need a negative pregnancy test and should use at least two forms of contraception, with monthly pregnancy tests as advised. Women should avoid pregnancy during treatment and for a further period afterwards, and male patients should ensure their partner does not become pregnant during and after treatment. It is also not for people with hemoglobinopathies such as thalassemia major or sickle-cell anaemia, or in combination with didanosine. Ask your doctor before use if you are breastfeeding or have other health conditions.

Frequently asked questions

What is Ribarin 200 mg Tablet used for and what kind of medicine is it?

It is an antiviral medicine containing ribavirin. It is used for chronic hepatitis C infection in adults, always together with other antiviral drugs, not on its own. It is prescribed for certain patients with compensated liver disease, including some who also have HIV.

How should Ribarin 200 mg Tablet be taken?

Swallow the tablet as your doctor tells you. The doctor decides the dose, how often it is taken and how long the course lasts, depending on your condition and the other medicines you take. Do not change the schedule yourself; ask your doctor or pharmacist if anything is unclear.

Which medicines may interact with Ribarin 200 mg Tablet?

It may interact with nucleoside reverse transcriptase inhibitors, and worsening toxicities may mean the dose is reduced or a medicine is stopped. Taking it with azathioprine has been linked to severe pancytopenia and a higher risk of azathioprine-related myelotoxicity. It is also not used with didanosine. Tell your doctor about all medicines you take.

Who should ask a doctor before using Ribarin 200 mg Tablet?

Pregnant women, women who may become pregnant, breastfeeding mothers, and people with hemoglobinopathies such as thalassemia major or sickle-cell anaemia should speak to a doctor first. Anyone with other health conditions or on other medicines should also check with their doctor before starting treatment.

Also available as

200 mg (Capsule)

Indications

Ribavirin is indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with other antiviral drugs in patients with compensated liver disease not previously treated with interferon alpha and in adult CHC patients coinfected with HIV. Ribavirin should not be used alone.

Pharmacology

Ribavirin is a synthetic nucleoside which has inhibitory action against respiratory syncytial virus, influenza virus and herpes simplex virus. The mechanism of action is not clear. It may act at several sites including cellular enzymes to interfere with viral nucleic acid synthesis. The mono- and triphosphate derivatives are known to be responsible for the antiviral action of the compound.

Dosage & Administration

The recommended duration of treatment for patients previously untreated with interferon is 24 to 48 weeks. After 24 weeks of treatment virologic response should be assessed. Treatment discontinuation should be considered in any patient who has not achieved an HCV RNA below the limit of detection of the assay by 24 weeks. There are no safety and efficacy data on treatment for longer than 48 weeks in the previously untreated patient population. In patients who relapse following interferon therapy, the recommended duration of treatment is 24 weeks. There are no safety and efficacy data on treatment for longer than 24 weeks in the relapse patient populations.

Ribavirin + Interferon: Genotype Ribavirin Daily Interferon alpha-2a Duration or interferon alpha-2b.
  • All <75 kg: (400+600) mg 3 MIU 3 times weekly 48 weeks Genotypes subcutaneously (Genotype1&4)
  • >75 kg: (600+600) mg 24 weeks (Genotype2&3)
Ribavirin + Peg-Interferon: Genotype Ribavirin Daily Peg-Interferon alpha-2a Duration or Peg-interferon alpha-2b:
  • 1 & 4 < 75 kg: (400+600) mg 180 gm once weekly 48 weeks
  • > 75 kg: (600+600) mg subcutaneously 2 & 3 (400+400) mg 24 weeks
Ribavirin may be administered without regard to food, but should be administered in a consistent manner. Drink plenty of water while being treated with this medication; drinking water will decrease the risk of serious side effects.

Interaction

Nucleoside reverse transcriptase inhibitors or reduce dose or discontinue interferon, ribavirin or both with worsening toxicities

Azathioprine: Concomitant use of azathioprine with ribavirin has been reported to induce severe pancytopenia and may increase the risk of azathioprine-related myelotoxicity.

Contraindications

Women who are pregnant. Ribavirin may cause fetal harm when administered to a pregnant woman. Ribavirin is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. Patients with hemoglobinopathies (e.g., thalassemia major or sickle-cell anemia). In combination with didanosine. Reports of fatal hepatic failure, as well as peripheral neuropathy, pancreatitis and symptomatic hyperlactatemia/lactic acidosis have been reported in clinical trials.

Side Effects

The most common adverse reactions in adults receiving combination therapy are psychiatric and central nervous system effects, severe ocular disorder, dental and periodontal disorders & growth inhibition in children and adolescents that may be irreversible in some patients. The most common adverse reactions in pediatric subjects were similar to those seen in adults.

Pregnancy & Lactation

Pregnancy Category X. Ribavirin produced significant embryocidal and/or teratogenic effects in all animal species in which adequate studies have been conducted. Malformations of the skull, palate, eye, jaw, limbs, skeleton and gastrointestinal tract were noted. The incidence and severity of teratogenic effects increased with escalation of the drug dose. Survival of fetuses and offspring was reduced.

Nursing Mothers: It is not known whether Ribavirin is excreted in human milk. Because many drugs are excreted in human milk and to avoid any potential for serious adverse reactions in nursing infants from ribavirin, a decision should be made either to discontinue nursing or therapy with Ribavirin, based on the importance of the therapy to the mother.

Precautions & Warnings

Birth defects and fetal death with ribavirin: Do not use in pregnancy and for 6 months after treatment. Patients must have a negative pregnancy test prior to therapy, use at least 2 forms of contraception and undergo monthly pregnancy tests. For a male patient, it is very important for his female partner to avoid becoming pregnant during treatment and during the 7 months after treatment and do not have sex with a pregnant women.

Storage Conditions

Keep out of the reach of children. Keep in a cool & dry place. Protect from light.

Alternative brands of Ribavirin

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.